News

Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany ...
PARSIPPANY, N.J. — Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle. The update ...
Ferring Pharmaceuticals and Posterity Health, a male fertility center of excellence, have partnered to launch a male fertility program. ... Male fertility issues are often treatable through lifestyle ...
Ferring’s success in developing oral formulations for peptide drugs including the world’s first orally active peptide, desmopressin (MINIRIN ®) and the fast dissolving lyophilisate (MINIRIN ...
Swiss specialty biopharma Ferring Pharmaceuticals and Berlin-based Alrise Biosystems agreed to work together to evaluate the latter’s ImSus ® drug delivery technology for the development of an ...
Ferring developed this heat-stable formulation of carbetocin to specifically address limitations in refrigeration and cold-chain transport of PPH medications in low- and lower-middle income ...
Infertility isn’t an easy subject to talk about — and Ferring Pharmaceuticals knows it. Challenges related to family planning have been associated with social stigmatization, particularly for female ...
RELATED: Ferring's C. difficile drug overcomes skepticism to secure FDA committee nod C. diff. is a superbug that resists antibiotics and other medications. The disorder causes roughly 500,000 ...
On the heels of an FDA speedy review for Keytruda’s potential use in non-muscle invasive bladder cancer (NMIBC), its close rival, a gene therapy by Ferring Pharmaceuticals spinout FerGene, has post ...
Ferring, which styles itself a research-driven pharmaceutical company, sells a variety of drugs for reproductive and women's health, urology and gastroenterology.
Ferring has another therapy in phase 3 trials for C. difficile in the form of the oral drug RBX7455. The company is also awaiting an FDA decision on its bladder cancer drug nadofaragene firadenovec.
Ferring, Israel’s MyBiotics ... collaboration agreement with Israeli life sciences firm MyBiotics Pharma Ltd. to treat a common vaginal infection using drugs based on the microbiome. ...